BioCentury | Dec 12, 2020
Regulation

CHMP’s December opinions include restrictions for Veklury in COVID, support for Daiichi, Seagen breast cancer drugs

...avatrombopag (AKR-501, E5501) Gilead Sciences Inc. Daiichi Sankyo Co. Ltd. Seagen Inc. AstraZeneca plc Innate Pharma S.A. Dynavax Technologies Corp. ViiV Healthcare Ltd. Celltrion Healthcare Co. Ltd. AbbVie Johnson...
BioCentury | Aug 12, 2020
Product Development

Data Bytes: Regeneron leads COVID-19 antiviral antibody pack

...collaboration with the Chinese Academy of Sciences and Lilly; Tychan Pte Ltd.; Sinocelltech Ltd. (Shanghai:688520); Celltrion Healthcare Co. Ltd....
...and Co. AbCellera Biologics Inc. Shanghai Junshi Biosciences Co. Ltd. Chinese Academy of Sciences Tychan Pte Ltd. Sinocelltech Ltd. Brii Biosciences Tsinghua University Celltrion Healthcare Co. Ltd. covid-19 cov19count chs2020 cov19count...
BioCentury | Mar 24, 2020
Product Development

March 23 COVID-19 roundup: Gilead looks to expand access to remdesivir, antiviral gains Orphan designation; plus N.Y.’s chloroquine trial, Celltrion and more

...drugs have yet to emerge (see “Industry to Boost Supply of Chloroquine” ). Celltrion, Junshi Celltrion Healthcare Co. Ltd....
BioCentury | Mar 16, 2020
Product Development

Teva, Celltrion launch fourth U.S. Herceptin biosimilar at modest discount

...compete on price, biosimilars manufacturers such as Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) and Celltrion Healthcare Co. Ltd....
BioCentury | Nov 26, 2019
Company News

Nov. 26 Company Quick Takes: Kyowa, Ardelyx expand partnership; plus ICER, Celltrion, Asahi-Veloxis and Merck

...Dec. 9 (see "Rinvoq Approval Bolster's AbbVie's Autoimmune Portfolio" ). Europe approves subcutaneous infliximab biosimilar Celltrion Healthcare Co. Ltd....
BioCentury | Mar 8, 2018
Company News

Management tracks: Takeda, Nimbus

...Hyoung-ki Kim has transitioned to CEO and vice chairman of the company's global marketing unit, Celltrion Healthcare Co. Ltd....
BioCentury | Mar 17, 2017
Finance

Mirae’s Western expansion

...biosimilar of MabThera from Roche (SIX:ROG; OTCQX:RHHBY). On March 14, Celltrion’s sales and marketing subsidiary, Celltrion Healthcare Co. Ltd....
BioCentury | Feb 23, 2017
Company News

Celltrion rituximab biosimilar approved; files for IPR of trastuzumab

...The European Commission approved Truxima biosimilar rituximab (CT-P10) from the Celltrion Healthcare unit of Celltrion Inc. (KOSDAQ:068270...
BioCentury | Aug 18, 2014
Company News

Celltrion, Mundipharma deal

...Celltrion’s Celltrion Healthcare Hungary Kft subsidiary granted Mundipharma exclusive commercialization rights in the U.K., Germany, Italy, Belgium...
BioCentury | Aug 15, 2014
Company News

Celltrion grants Remsima marketing rights to Mundipharma

...Celltrion Inc. (KOSDAQ:068270) subsidiary Celltrion Healthcare Hungary Kft granted Mundipharma International Ltd. (Cambridge, U.K.) exclusive distribution rights...
Items per page:
1 - 10 of 11
BioCentury | Dec 12, 2020
Regulation

CHMP’s December opinions include restrictions for Veklury in COVID, support for Daiichi, Seagen breast cancer drugs

...avatrombopag (AKR-501, E5501) Gilead Sciences Inc. Daiichi Sankyo Co. Ltd. Seagen Inc. AstraZeneca plc Innate Pharma S.A. Dynavax Technologies Corp. ViiV Healthcare Ltd. Celltrion Healthcare Co. Ltd. AbbVie Johnson...
BioCentury | Aug 12, 2020
Product Development

Data Bytes: Regeneron leads COVID-19 antiviral antibody pack

...collaboration with the Chinese Academy of Sciences and Lilly; Tychan Pte Ltd.; Sinocelltech Ltd. (Shanghai:688520); Celltrion Healthcare Co. Ltd....
...and Co. AbCellera Biologics Inc. Shanghai Junshi Biosciences Co. Ltd. Chinese Academy of Sciences Tychan Pte Ltd. Sinocelltech Ltd. Brii Biosciences Tsinghua University Celltrion Healthcare Co. Ltd. covid-19 cov19count chs2020 cov19count...
BioCentury | Mar 24, 2020
Product Development

March 23 COVID-19 roundup: Gilead looks to expand access to remdesivir, antiviral gains Orphan designation; plus N.Y.’s chloroquine trial, Celltrion and more

...drugs have yet to emerge (see “Industry to Boost Supply of Chloroquine” ). Celltrion, Junshi Celltrion Healthcare Co. Ltd....
BioCentury | Mar 16, 2020
Product Development

Teva, Celltrion launch fourth U.S. Herceptin biosimilar at modest discount

...compete on price, biosimilars manufacturers such as Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) and Celltrion Healthcare Co. Ltd....
BioCentury | Nov 26, 2019
Company News

Nov. 26 Company Quick Takes: Kyowa, Ardelyx expand partnership; plus ICER, Celltrion, Asahi-Veloxis and Merck

...Dec. 9 (see "Rinvoq Approval Bolster's AbbVie's Autoimmune Portfolio" ). Europe approves subcutaneous infliximab biosimilar Celltrion Healthcare Co. Ltd....
BioCentury | Mar 8, 2018
Company News

Management tracks: Takeda, Nimbus

...Hyoung-ki Kim has transitioned to CEO and vice chairman of the company's global marketing unit, Celltrion Healthcare Co. Ltd....
BioCentury | Mar 17, 2017
Finance

Mirae’s Western expansion

...biosimilar of MabThera from Roche (SIX:ROG; OTCQX:RHHBY). On March 14, Celltrion’s sales and marketing subsidiary, Celltrion Healthcare Co. Ltd....
BioCentury | Feb 23, 2017
Company News

Celltrion rituximab biosimilar approved; files for IPR of trastuzumab

...The European Commission approved Truxima biosimilar rituximab (CT-P10) from the Celltrion Healthcare unit of Celltrion Inc. (KOSDAQ:068270...
BioCentury | Aug 18, 2014
Company News

Celltrion, Mundipharma deal

...Celltrion’s Celltrion Healthcare Hungary Kft subsidiary granted Mundipharma exclusive commercialization rights in the U.K., Germany, Italy, Belgium...
BioCentury | Aug 15, 2014
Company News

Celltrion grants Remsima marketing rights to Mundipharma

...Celltrion Inc. (KOSDAQ:068270) subsidiary Celltrion Healthcare Hungary Kft granted Mundipharma International Ltd. (Cambridge, U.K.) exclusive distribution rights...
Items per page:
1 - 10 of 11